What happens when you’re not constrained by the limits of traditional manufacturing? Boas explains how 3D printing has empowered his team to leave behind the compromises of extrusion and laser cutting ...
“High quality, large-scale, fit-for-purpose datasets” continues to be the tagline for artificial intelligence (AI) models aiming to achieve scalable drug discovery to novel targets. While troves of ...
Synthetic Design Lab Inc., which emerged from stealth with a $20 million seed round and a platform technology aimed at advancing the antibody-drug conjugate (ADC) space, began with its founders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback